Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Basic Science (Oncology): Tumor Characterization & Microenvironment

  • You have access
    First clinical observations of HER2 specific [111In]ABY-025 metastatic detection capability in females with metastatic breast cancer
    Dan Sandberg, Anders Wennborg, Joachim Feldwisch, Vladimir Tolmachev, Jörgen Carlsson, Ulrike Garske, Jens Sörensen and Henrik Lindman
    Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 220;
  • You have access
    Quantitative analysis of [18F]FMISO PET for tumor hypoxia: Correlation with results using immunohistochemistry
    Kuangyu Shi, Constantin Maftei, Christine Bayer, Sabrina Astner, Florian Gaertner, Peter Vaupel, Markus Schwaiger, Sung-Cheng Huang and Sibylle Ziegler
    Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 216;
  • You have access
    Kras mutation causes increased 18F-FDG uptake in experimental models of colorectal cancer
    Pedram Heidari, Mark Sinnamon, Peiman Habibollahi, Kenneth Hung and Umar Mahmood
    Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 215;
  • You have access
    DCE-MRI following intraperitoneal gadodiamide injection for multimodal imaging of the tumor microenvironment
    Veerle Kersemans, Philip Allen, Bart Cornelissen and Sean Smart
    Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 218;
  • You have access
    99mTc-3PRGD2 SPECT/CT allows noninvasive detection of human induced pluripotent stem cell (hiPSC)-derived teratoma
    Zhaofei Liu, Yang Li, Chengyan Dong, Bing Jia and Fan Wang
    Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 221;
  • You have access
    Correlation of (4S)-4-(3-[18F]fluoropropyl)-L-glutamate ([18F]FSPG) uptake by positron emission tomography (PET) with immunohistochemical expression of system xC- and CD44 in cancer patients
    Sora Baek, Gyungyub Gong, Chang-Min Choi, Norman Koglin, Christoph Schatz, Andre Mueller, Claudia Bacher-Stier, Lueder Fels, Ludger Dinkelborg and Dae Hyuk Moon
    Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 219;
  • You have access
    Evaluation of 99mTc-labeled small molecule inhibitors of carbonic anhydrase (CA) for imaging hypoxia
    Shawn Hillier, Genliang Lu, Kevin Maresca, John Marquis, Trevor McKee, David Green, William Eckelman, Brad Wouters, John Joyal and John Babich
    Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 217;
SNMMI

© 2025 SNMMI

Powered by HighWire